Patent ID: 8877809
Filing Date: 2014-11-04
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method of retarding the accumulation of a lipofuscin pigment in a retina, comprising administering an effective amount of a pharmaceutical composition to a patient in need thereof, wherein the pharmaceutical composition comprises a substituted C 20 -D 1-3 -retinoid, wherein the C 20 -D 1-3 -retinoid is selected from the group consisting of C 20 -D 1-3 -retinol C 20 -D 1-3 -retinol ester, C 20 -D 1-3 -retinal and C 20 -D 1-3 -pro-vitamin A carotenoids, and a pharmaceutically acceptable carrier.